FDA Investigator Dana A Razzano
Dana A Razzano has inspections in 9 countries as of 16 Nov 2023. Dana A Razzano has collaborated with a combined 2916 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
215
Last Inspection Date:
16 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Morocco,
Indonesia,
Uruguay,
Japan,
Canada,
Maldives,
Armenia
Co-Investigator(s):
Alice C Silva,
Alysia M Salonia,
Alyssa R Favro,
Amanda T Zick,
Amy W Yan Mai,
Andrew F Cohen,
Ann B Okon,
Anne Marie Dubrey,
Arduino Frankovic,
Armen H Youssoufian,
Arthur F Walker,
Arthur G Hurst,
Ashley Defilippis,
Benton M Ketron,
Bradford L Swanson,
Brenna L Macdowell,
Brian R Yaun,
Bruce G Cooper,
Carley R Anderson,
Carolyn J Cook,
Carr,
Catherine M Beer,
Celena Ngo,
Christopher J Cruciotti,
Christopher M Elliott,
Clara E Santiago,
Clinton V Giustra,
Cullen T Wilson,
Dana M Lewis,
Daniel J Lahar,
Daniel L Aisen,
David A Laplante,
Denise L Terzian,
Diamond M Oden,
Diane M Fresch,
Diantha M Bleau,
Diantha M Turner,
Dominic R Frasca,
Donald G Gordon,
Donald J Ullstrom,
Ellen M Landis,
Emily J Schramm,
Eric J Reisenauer,
Erica B Raphael,
Erich P Garger,
Erik W Koester,
Erin L Nagel,
Frank J Koch,
Frank Wackes,
Gam S Zamil,
Geoffrey B Ward,
George C Amedro,
Gerald T O'connor,
Gray,
Hilary K Wagner,
Intkhab H Wahla,
Isaac N Baah,
James K Mcnally,
James R Montero,
James R Wormuth,
Jamie S Mathews,
Jeffrey N Gerdes,
Jennifer L Johnson,
Jessica B Zachman,
Joel R Merriman,
John A Hollings,
John P Shelton,
John T Sproul,
Jonathan B Lewis,
Joseph Maselli,
Joseph T Frost,
Joshua D Lopez,
Joy P Matthias,
Joyce A Kellett,
Joyce A Williams,
Juan Rjimenez Garcia,
Juanita P Versace,
Judy Keihl,
Julie Scoma,
Karla J Gibler,
Katherine M Taylor,
Kathleen E Mcafoose,
Kathryn A Nagy,
Kazi Rafiquzzaman,
Kenneth G Klobus,
Kimberley A Ricketts,
Kimberly M White,
Kimberly Y Smithson,
Kristen E Szenderski,
Kwong P Lee,
Kyle J Spencer,
Lawrence H Patrick,
LCDR Chad N Thompson,
Lenita R Silvera,
Lirissia Mccoy,
Lisa Mathew,
Liz M Otero,
Lourdes Andujar,
Margaret E Sarles,
Marie Elena C Puleo,
Marlon K Turner,
Mary Jeanet Mcgarry,
Mary M Finn,
Matthew A Johnson,
Meisha A Mandal,
Melissa A Henaghan,
Melissa N Gregorio,
Michael A Charles,
Michael G Sinkevich,
Michael R Dominick,
Michael W Burd,
Michelle M Noe,
Mikayla K Deardorff,
Milan S Mcgorty,
Morgan J Matthews,
Nancy A Saxenian,
Nancy A Saxenian Emmons,
Nasser Yazdani,
Natalie A Guidry,
Nicholas C Mendiola,
Nicholas J Scire,
Nichole B Murphy,
Nina D Patel,
Paul E Stein,
Paul M Gelfand,
Perez,
Perry T Nichols,
Peter M Trunk,
Peter R Caparelli,
Randi Lynn Bodoh,
Randi Lynn Spencer,
Raymond M Lam,
Rebecca A Coleman,
Rebecca B Welch,
Richard F Hapke,
Ricki A Chase,
Ricki Achase Off,
Robert D Ogan,
Robert J Veitch,
Rupa Pradhan,
Russ E Davis,
Samuel A Francis,
Samuel M Salerno,
Sasha M Latonis,
Scott R Izyk,
Secrist,
Sherona A Ryder,
Shreya Shah,
Simone E Pitts,
Slater K Bartlett,
Smith,
Sonia E Ortiz,
Stanley E Malcolm,
State Agency,
Steven J Libal,
Suwaskie S Smith,
Tamara M Simpson,
Tammy S Notto,
Tessa M Geary,
Tessa M Latham,
Thomas J Hudson,
Todd D Alspach,
Tressa T Lewis,
Troy R Petrillo,
Uduak M Inokon,
Valerie A Potopsingh,
Walter H Stanley,
Wendy A Johnecheck,
Wendy M Stone,
William M Rennells,
William P Chilton,
Yvonne M Santiago
Dana A Razzano's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2014 | FDA 483 | Prime Health Products - Form 483, 2014-09-10 |
September, 2014 | FDA 483 | Trans-Herbe, Inc. - Form 483, 2014-09-19 |
March, 2017 | FDA 483 | Vulto Creamery - Form 483, 2017-03-22 |
January, 2013 | EIR | Curia New York, Inc. - EIR, 2013-01-30 |
January, 2013 | FDA 483 Response | Curia New York, Inc. - Form 483R, 2013-01-30 |
January, 2013 | FDA 483 | Curia New York, Inc. - Form 483, 2013-01-30 |
September, 2014 | FDA 483 | Sanda Pastries, Inc. - Form 483, 2014-09-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more